Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ocular adverse drug reactions.

F W Fraunfelder1

  • 1Casey Eye Institute and the National Registry of Drug-Induced Ocular Side Effects, 3375 SW Terwilliger Boulevard, Portland, OR 97201-4197, USA. eyedrug@ohsu.edu

Expert Opinion on Drug Safety
|August 9, 2003
PubMed
Summary

This review details drug-induced ocular side effects, classifying adverse events and highlighting clinical importance. It provides guidelines for recognizing, reporting, and treating these reactions, addressing pharmacovigilance in ocular toxicology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Keratitis in association with herpes zoster and varicella vaccines.

Drugs of today (Barcelona, Spain : 1998)·2017
Same author

Casey Eye Institute camera system for recording lens opacities.

Experimental eye research·2011
Same author

Interferon alfa-associated anterior ischemic optic neuropathy.

Ophthalmology·2010
Same author

Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use.

Ophthalmology·2008
Same author

Toxicities of topical ophthalmic anesthetics.

Expert opinion on drug safety·2007
Same author

Corneal toxicity from topical ocular and systemic medications.

Cornea·2006

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Toxicology

Background:

  • Drug-induced ocular side effects are a significant concern in patient care.
  • Understanding these adverse events is crucial for maintaining ocular health.
  • Existing literature and registries provide valuable data on these reactions.

Purpose of the Study:

  • To comprehensively review drug-induced ocular side effects.
  • To categorize adverse events based on established criteria.
  • To provide practical guidelines for managing ocular drug reactions.

Main Methods:

  • Literature review of recent reports.
  • Analysis of data from the National Registry of Drug-Induced Ocular Side Effects.
  • Inclusion of information from the World Health Organization (WHO) and FDA.

Main Results:

  • Adverse events are categorized by certainty (certain, probable/likely, possible, unlikely, conditional/unclassified, unassessable/unclassifiable).
  • Ocular side effects of clinical importance are identified and highlighted.
  • Guidelines for recognition, reporting, and treatment of adverse drug reactions (ADRs) are presented.

Conclusions:

  • Effective pharmacovigilance is essential for ocular toxicology.
  • Timely recognition and management of ADRs can mitigate vision impairment.
  • Future pharmacovigilance strategies are needed to address emerging ocular toxicities.

Related Experiment Videos